Bangladesh vs Sur: Previously treated cases tested for RR-/MDR-TB
Bangladesh
100.0%
in 2024
Sur
62.0%
in 2024
Bangladesh rank
1st
Sur rank
2nd
Previously treated cases tested for RR-/MDR-TB over time
- Bangladesh
- Sur
How they compare
Bangladesh currently reports 100.0% against 62.0% in Sur, a difference of 38.0%.
That makes Bangladesh's figure about 1.6 times Sur's.
The two have swapped places 6 times across 14 shared years of data; in 2011 it was Bangladesh ahead.
Bangladesh ranks 1st and Sur ranks 2nd of 180 countries.
Bangladesh has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bangladesh | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 56.7% | 53.0% | 3.7% | Bangladesh |
| 2020s | 96.0% | 78.4% | 17.6% | Bangladesh |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Bangladesh or Sur?
- Bangladesh, at 100.0% against 62.0% in Sur as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Bangladesh and Sur?
- 38.0%, with Bangladesh ahead.
- How many years of comparable data are there for Bangladesh and Sur?
- 14 years are reported by both, from 2011 to 2024.
- How do Bangladesh and Sur rank globally for previously treated cases tested for rr-/mdr-tb?
- Bangladesh ranks 1st and Sur ranks 2nd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.